Reference
WHO. Pegaspargase: Risk of hypersensitivity reactions. WHO Pharmaceuticals Newsletter : No. 4, 2023. Available from: URL: https://iris.who.int/bitstream/handle/10665/373827/9789240082656-eng.pdf?sequence=1#page=6&zoom=100,537,117
Rights and permissions
About this article
Cite this article
Pegaspargase: risk of hypersensivity reactions. Reactions Weekly 1983, 4 (2023). https://doi.org/10.1007/s40278-023-49353-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-49353-x